Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Summit Raises $500m For Shift From Anti-Infectives To Oncology

Proceeds Will Repay Debt, Fund Phase III Trials

07 Mar 2023

• By Mandy Jackson

Finance Watch Public Company — • Source: Alamy

Related Content

Theravance Dumps JAK Inhibitor Program, Focuses On Neurogenic Orthostatic Hypotension

28 Feb 2023

Troubled Adamis To Merge With Private DMK, Focus On Neurological Disease

28 Feb 2023

Travere’s Filspari US Approval Marks First For IgAN

20 Feb 2023

Apellis Set For Blockbuster Success With Syfovre, The First Approved Geographic Atrophy Drug

20 Feb 2023

G1’s Cosela Could Show Promise In Triple-Negative Breast Cancer Despite Colorectal Cancer Fail

14 Feb 2023

Aptinyx Pulls Back From Neuropsychiatry After Mid-Stage PD Failure

01 Mar 2023

Summit's Lead Antimicrobial Fails Pivotal Study, May Spark Therapeutic Shift

22 Dec 2021

MorphoSys Takes $252.1m Impairment Charge As It Slims Down R&D

11 Mar 2022

Orchard and Zealand Join Growing List Of Biotechs On The Ropes

31 Mar 2022

Finance Watch: Public Market Opens Up Enough To Let An IPO Through

02 Aug 2022

Finance Watch: Prime Medicine Launches Second-Largest IPO In Second Half Of 2022

20 Oct 2022

Santhera Finalizes Vamorolone Filings And Now Seeks Funds

31 Oct 2022

Finance Watch: Recent M&A Uptick Gives Biopharma A Needed Boost

21 Jul 2022

Finance Watch: Third Harmonic Attempts A Flight Through The IPO Window

24 Aug 2022

BMS's Abecma Faces J&J Threat Despite Pivotal Success In Earlier Myeloma Setting

13 Feb 2023

Finance Watch: Public Biopharma Firms Take Advantage Of Relative Upswing

19 Dec 2022

Summit Bets On Akeso IO Bispecific Despite China Firms’ Issues With US FDA

06 Dec 2022

Related Companies

Summit Therapeutics plc

Akeso Inc.

Pharmacyclics, Inc.

Teva Pharmaceutical Industries Ltd.

Apellis Pharmaceuticals, Inc.

Revolution Medicines, Inc.

Travere Therapeutics, Inc.

Orchard Therapeutics Limited

2seventy Bio, Inc.

Oculis S.A.

Novavax, Inc.

Aptinyx, Inc.

Theravance Biopharma Inc.

DMK Pharmaceuticals Corp.

atai Life Sciences BV

MorphoSys AG

G1 Therapeutics Inc.

Santhera Pharmaceuticals

Additional Topics

Restructuring Financing StartUps and SMEs Business Strategies Commercial Finance Watch BioPharmaceutical

More from Finance Watch

More from Financing

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.